Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings

Area of Science:

• Pediatric Pharmacology
• Global Health
• Pharmaceutical Development

Background:

• Despite regulatory efforts, a significant gap persists in developing age-appropriate medicines for children.
• Resource-poor regions face unique barriers, including disease burden, financial constraints, and fragmented healthcare systems, exacerbating this unmet need.
• The lack of approved pediatric formulations often leads to the off-label use of adult medications, increasing risks of incorrect dosing and adverse events.

Purpose of the Study:

• To provide an overview of the challenges in pediatric medicine development.
• To highlight shared and location-specific difficulties, opportunities, and innovative solutions.
• To discuss the potential of platform technologies for pediatric drug development in resource-limited settings.

Main Methods:

• Literature review and analysis of existing challenges in pediatric medicine development.
• Examination of regulatory landscapes and initiatives.
• Exploration of specific dosage forms and platform technologies relevant to low and middle-income countries (LMICs).

Main Results:

• Key difficulties in pediatric medicine development are identified across high and low-resource settings.
• Area-specific challenges, such as disease prevalence and economic factors, significantly impact formulation availability.
• Dispersible oral dosage forms and suppositories show promise for LMICs, alongside other emerging technologies.

Conclusions:

• Addressing the unmet need for pediatric medicines requires overcoming significant global and local challenges.
• Innovative approaches and accessible technologies are crucial for improving the availability and safety of pediatric medications, particularly in resource-limited environments.
• Further research and development into platform technologies are essential for advancing pediatric medicine accessibility worldwide.